BOLT · ISSUER CIK 1641281
Bolt Biotherapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Bolt Biotherapeutics, Inc. insiders reported $4K of open-market purchases and $128K of sales on SEC Form 4. The largest buyer was Quinn William P. (President, CEO and CFO, Director), with $2K.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 3 sales were reported under a 10b5-1 plan.
$4KInsider buying
$128KInsider selling
−$124KNet open-market
Oct 27, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 202617:21 | Oct 23, 2026 | BOLT | Chief Strategy Officer, Director | A · Grant | — | +85,821 | 72,766 | — | — | ||
| Sep 21, 202618:05 | Sep 18, 2026from Sep 16, 2026 | BOLT | Chief Operating Officer | S · Sell | $3.32 | −13,176 | 17,269 | -43% | −$44K | ||
| Sep 21, 202618:04 | Sep 18, 2026from Sep 16, 2026 | BOLT | Senior VP, Finance and PAO | S · Sell | $3.32 | −7,842 | 17,082 | -31% | −$26K | ||
| Sep 21, 202618:04 | Jun 5, 2026 | BOLT | Senior VP, Finance and PAO | P · BuyLate 108d | $3.88 | +509 | 1,924 | +36% | +$2K | -28.1% | +64.1% |
| Sep 21, 202618:03 | Sep 18, 2026from Sep 16, 2026 | BOLT | President, CEO and CFO, Director | S · Sell | $3.32 | −17,566 | 25,384 | -41% | −$58K | ||
| Sep 21, 202618:03 | Jun 5, 2026 | BOLT | President, CEO and CFO, Director | P · BuyLate 108d | $3.88 | +637 | 2,950 | +28% | +$2K | -28.1% | +64.1% |